zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2022 / Oneness Biotech Co., Ltd. received an India patent on FB704A, an anti-IL6 fully-human antibody new drug.

Oneness Biotech Co., Ltd. received an India patent on FB704A, an anti-IL6 fully-human antibody new drug.

2022-03-11

Published Date:2022-03-11

Original Link:https://www.onenessbio.com/en/news_detail148_3.htm

No 1 Date of announcement 2022/03/11 Time of announcement 17:56:11
Subject Oneness Biotech Co., Ltd. received an India patent on FB704A, an anti-IL6 fully-human antibody new drug.
To which item it meets paragraph 53 Date of events 2022/03/11
Statement
  1. Date of occurrence of the event: 2022/03/11
  2. Company name: ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter “head office” or “subsidiaries”): head office
  4. Reciprocal shareholding ratios: NA
  5. Cause of occurrence:
    The Company has been informed by the patent agency that the FB704A, an anti-IL6 fully-human antibody new drug, has been granted an India patent titled “ANTIBODIES TO INTERLEUKIN-6 AND USES THEREOF” under the patent number 389592.
  6. Countermeasures: None
  7. Any other matters that need to be specified: None